Timothy Sullivan
Nessuna posizione attualmente
Storia della carriera di Timothy Sullivan
Precedenti posizioni note di Timothy Sullivan
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ARCUS BIOSCIENCES, INC. | Corporate Officer/Principal | 01/01/2017 | 01/05/2020 |
| PFIZER, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2015 | 01/01/2017 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01/12/2012 | 01/06/2015 |
| CHEMOCENTRYX, INC. | Corporate Officer/Principal | 01/03/2010 | 01/12/2012 |
Formazione di Timothy Sullivan
| University of Notre Dame | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
| Giappone | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ARCUS BIOSCIENCES, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Aziende private | 1 |
|---|---|
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology ChemoCentryx, Inc. is a biopharmaceutical company, which engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA. | Health Technology |
- Borsa valori
- Insiders
- Timothy Sullivan
- Esperienza
